In fact, there is evidence of overexpression of BCL-2, BCL-xL, and MCL-1, which are anti-apoptotic molecules, in KIT D816V-positive neoplastic MCs in SM patients [56,57,58]. This evidence concerns the gene KIT and systemic mastocytosis.